Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P33 - Pathology - Immunotherapy Biomarker

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P33.07 - Peripheral CD4+ T cell Signatures in Predicting Response to Anti-PD-1 Monotherapy for Chinese Advanced Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Ying Wang

      • Abstract

      Loading...

  • +

    P36 - Pathology - Prognosis

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P36.02 - CHEK1: Unfavourable Prognostic Hub Gene and Potential Therapeutic Target for Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: 谭 Tan

      • Abstract

      Loading...

  • +

    P42 - Screening and Early Detection - Risk Modelling and Artificial Intelligence

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P42.03 - A Dynamic Deep Learning Approach to Predict Clinical Outcomes of Patients with Advanced Non-Small Cell Lung Cancer under Nivolumab Monotherapy

      00:00 - 00:00  |  Presenter: Shun Lu

      • Abstract

      Loading...

  • +

    P63 - Tumor Biology and Systems Biology - Basic and Translational Science - Metastases

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P63.03 - M1 Phenotype Polarization of Microglia via MIF/CD74 Axis for Radiosensitization in NSCLC Brain Metastasis

      00:00 - 00:00  |  Presenter: Xiaorong Dong

      • Abstract

      Loading...

    • +

      P63.04 - Dysbiosis of Sputum and Gut Microbiota Modulate Development and Distant Metastasis of Non-Small Cell Lung Carcinomas

      00:00 - 00:00  |  Presenter: Jiaojiao Wang

      • Abstract

      Loading...

  • +

    P72 - Tumor Biology and Systems Biology - Basic and Translational Science - Tumor Microenvironment

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      P72.06 - NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME

      00:00 - 00:00  |  Presenter: Liliang Xia

      • Abstract

      Loading...

  • +

    P89 - Targeted Therapy - Clinically Focused - Translational

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P89.14 - Preliminary Study on CTCs and CTECs in Non-Small Cell Lung Cancer Received Chemotherapy Combined with Anti-Angiogenic Therapy

      00:00 - 00:00  |  Presenter: LINA Zhang

      • Abstract

      Loading...

  • +

    OA01 - Established Drugs in Special Populations and New Drugs in Established Populations

    • 09:15 - 10:15
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      OA01.06 - Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC

      09:40 - 09:50  |  Presenter: Gillianne Geet Yi Lai

      • Abstract

      Loading...

  • +

    MA13 - Tumor Biology: Focus on EGFR Mutation, DNA Repair and Tumor Microenvironment

    • 16:45 - 17:45
    • 1/31/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      MA13.08 - Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

      17:25 - 17:30  |  Presenter: Aaron C Tan

      • Abstract

      Loading...